Acorn Regulatory’s Essential Guide to Clinical & Medical Affairs
Our Clinical & Medical Affairs Services team works with companies all around the world and assists them with issues such as clinical trials, medical writing services, and medical information services. They have also taken the time to write some of...
Carrying Out A Clinical Investigation Under MDR
As part of our ongoing MDR series, we are looking at clinical investigations and how they will operate after the MDR has been introduced. We have written extensively on the MDR issues and at the end of this article, you...
Download the 3rd Acorn Regulatory MDR Whitepaper
The 3rd Acorn Regulatory MDR whitepaper is available now. This publication looks at Clinical Evaluation Reports, Conformity Assessment Routes and Clinical Investigations under MDR.
Acorn Regulatory NewsBrexitChristine McGrathClinical & MedicalDanica CvetkovicGemma RobinsonMarie CarrollMarketing Authorisation HoldersPharmacovigilancePublicationsRegulatory Strategy
Download ‘Regulatory Intelligence 6’ Now
‘Regulatory Intelligence 6’ from Acorn Regulatory looks at the latest trends and issues in the sector. You can download your edition of the e-book by completing the form below.
Most Read Pharmacovigilance & Medical Articles of 2019
Our pharmacovigilance and medical teams have had a busy 2019. During the course of the year they have taken the time to write some very well received articles about PV, medical and clinical issues. Here, we have compiled 4 of...
‘PV Update’: Get Our Pharmacovigilance E-Book Now
Acorn Regulatory’s pharmacovigilance and medical teams work with some of the largest and most dynamic companies in the world. They have looked at the major issues impacting their clients at the moment and have created ‘PV Update’ which is our...
Will Clinical Trials Be Impacted By Brexit?
How will clinical trials be impacted by the UK’s decision to leave the European Union? The United Kingdom’s decision to leave the European Union (EU) will present significant implications to the pharmaceutical industry. Clinical trial sponsors and associated partners should...
Guidelines For Notification of Serious Breaches of Regulation (EU) No. 536/2014
Marie Carroll from our regulatory team looks at the steps that need to be taken when there is a serious breach of EU regulation No. 536/2014. The European Medicines Agency describes the regulation as: The goal of Clinical Trial Regulation EU No....
Preparing the Reference Safety Information for a Clinical Trial
What are the steps that companies need to take when preparing the reference safety information for a clinical trial? This article looks at the steps that you need to take.
Blog: Clinical Trials and Brexit
In this blog, Brian Cleary looks at clinical trials and Brexit. He also looks at the issues surrounding the UK’s departure from the European Union.
By using this website, you agree to our
cookie policy.
Close